it can be risky
Research using synthetic sponge implantation modelsa standard method for assessing angiogenesisshows TB-500 significantly increases vessel density and organization compared to controls
If youre the kind of patient who loves the idea of cutting-edge science and biohacks, MOTS-c is one to watch
Clear, stable, and dependable for accurate research preparation
For the full BPC-157 dosing breakdown, see our BPC-157 dosage protocol guide: BPC-157: 200 to 500 mcg per day, subcutaneous injection near the injury site, 4 to 8 weeks TB-500 loading phase (Weeks 1-4): 2 to 5 mg twice per week TB-500 maintenance phase (Weeks 5-8): 2 mg once per week Route: Both peptides are administered via subcutaneous injection
There are three options for BPC-157, the Rapid, the Delayed, and the Original Formula